Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030

Fluorescent in Situ Hybridization (FISH) Market Report: Trends, Forecast and Competitive Analysis to 2030

Fluorescent in Situ Hybridization (FISH) Trends and Forecast

The future of the global fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets. The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030 with a CAGR of 7.6% from 2024 to 2030. The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Fluorescent in Situ Hybridization (FISH) by Segment

The study includes a forecast for the global fluorescent in situ hybridization (FISH) by product type, technology, application, end use, and region.

Fluorescent in Situ Hybridization (FISH) Market by Product Type [Shipment Analysis by Value from 2018 to 2030]:

• Consumables
• Instrument
• Software

Fluorescent in Situ Hybridization (FISH) Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

• DNA Fluorescent in Situ Hybridization
• RNA Fluorescent in Situ Hybridization
• PNA Fluorescent in Situ Hybridization
• Others

Fluorescent in Situ Hybridization (FISH) Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Cancer Research
• Genetic Research
• Infectious Disease
• Personalized Medicine
• Others

Fluorescent in Situ Hybridization (FISH) Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals & Clinics
• Diagnostic Laboratories
• Pharmaceuticals & Biotechnology Companies
• Contract Research Organisations
• Academic & Research Organisations
• Others

Fluorescent in Situ Hybridization (FISH) Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Fluorescent in Situ Hybridization (FISH) Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies fluorescent in situ hybridization (FISH) companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the fluorescent in situ hybridization (FISH) companies profiled in this report include-

• Abnova Corporation
• Agilent Technologies
• Biocare Medical
• Biodot
• F. Hoffmann-LA Roche
• Genemed Technologies
• Merck
• PERKINELMER
• Qiagen
• Thermo Fisher Scientific

Fluorescent in Situ Hybridization (FISH) Market Insights

Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Within this market, cancer research is expected to witness the highest growth due to increasing prevalence of cancer and rising government support for cancer research.

North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Features of the Global Fluorescent in Situ Hybridization (FISH) Market

Market Size Estimates: Fluorescent in situ hybridization (FISH) market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Fluorescent in situ hybridization (FISH) market size by various segments, such as by product type, technology, application, end use, and region in terms of value ($B).

Regional Analysis: Fluorescent in situ hybridization (FISH) market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, technologies, applications, end uses, and regions for the fluorescent in situ hybridization (FISH) market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the fluorescent in situ hybridization (FISH) market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the fluorescent in situ hybridization (FISH) market size?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to reach an estimated $1.84 billion by 2030.

Q2. What is the growth forecast for fluorescent in situ hybridization (FISH) market?

Answer: The global fluorescent in situ hybridization (FISH) market is expected to grow with a CAGR of 7.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the fluorescent in situ hybridization (FISH) market?

Answer: The major drivers for this market are rising cases of cancer and genetic diseases and on-going advancements in FISH products.

Q4. What are the major segments for fluorescent in situ hybridization (FISH) market?

Answer: The future of the fluorescent in situ hybridization (FISH) market looks promising with opportunities in the cancer research, genetic research, infectious disease, and personalized medicine markets.

Q5. Who are the key fluorescent in situ hybridization (FISH) market companies?

Answer: Some of the key fluorescent in situ hybridization (FISH) companies are as follows:

• Abnova Corporation
• Agilent Technologies
• Biocare Medical
• Biodot
• F. Hoffmann-LA Roche
• Genemed Technologies
• Merck
• PERKINELMER
• Qiagen
• Thermo Fisher Scientific

Q6. Which fluorescent in situ hybridization (FISH) market segment will be the largest in future?

Answer: Lucintel forecasts that consumables will remain the largest segment over the forecast period.

Q7. In fluorescent in situ hybridization (FISH) market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to growing investment in research and development of breast cancer and infectious disease treatment in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the fluorescent in situ hybridization (FISH) market by product type (consumables, instrument, and software), technology (DNA fluorescent in situ hybridization, RNA fluorescent in situ hybridization, PNA fluorescent in situ hybridization, and others), application (cancer research, genetic research, infectious disease, personalized medicine, and others), end use (hospitals & clinics, diagnostic laboratories, pharmaceuticals & biotechnology companies, contract research organisations, academic & research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Please note: It will take 2-3 business days to deliver the report upon receipt the order.